Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K0TO
|
||||
| Former ID |
DNC011302
|
||||
| Drug Name |
NSC-78017
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C13H13N2+
|
||||
| Canonical SMILES |
CC1=CC2=C(N1)C=CC3=C2C=CC=[N+]3C.[I-]
|
||||
| InChI |
1S/C13H12N2.HI/c1-9-8-11-10-4-3-7-15(2)13(10)6-5-12(11)14-9;/h3-8H,1-2H3;1H
|
||||
| InChIKey |
YMNYODFONHNLBW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.